In vitro diagnostic solution for rapid COVID-19 detection. Provides point-of-care testing capabilities for viral identification.
Manufactured by
Nanjing, China
Lansion Biotechnology Co., Ltd.(Lansionbio) was established in Nanjing, China in 2016. As one high-tech enterprise and key technology-based enterprise, Lansionbio is committed to the research development, production, sales and service of in vitro diagnostic reagents and devices. Through the integrated multi-platform POCT workstation, it provides medical units and families with comprehensive solutions for on-site rapid detection, and has become a representative enterprise of the new generation of laboratory medicine industry ecology in China. Since 2020, Lansionbio has been actively involved in the prevention and control of the global COVID-19 epidemic, and its related products have obtained CE certification and product registration in many countries, and are exported to more than 50 countries and regions outside of China.
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
DIA.PRO Diagnostic BioProbes Srl
Italy · 1 relevant product
CerTest Biotec S.L.
Spain · 1 relevant product
LumiQuick Diagnostics, Inc.
United States · 1 relevant product
Monobind Inc.
United States · 1 relevant product
Bio-Techne Diagnostics
United States · 1 relevant product
Shenzhen Dymind Biotechnology Co.,Ltd.
China · 2 relevant products
Convergent Technologies GmbH & Co. KG
Germany · 1 relevant product
Guangzhou Wondfo Biotech Co., Ltd.
China · 1 relevant product
Acon Biotech (Hangzhou) Co., Ltd.
China · 1 relevant product
Nanjing Liming Bio-products Co., Ltd.
China · 1 relevant product
85 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →6 more sourcing countries available
Get free access to all sourcing countries identified for this product.
See all countries →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
12 of 115 closest product alternatives
DIA.PRO Diagnostic BioProbes Srl · Italy
A diagnostic testing solution for COVID-19 detection. The company offers PCR-based assays for SARS-CoV-2 detection, with verification against new variants such as Omicron B.1.1.529. Products include RT-PCR assays and ELISA kits for IgM monitoring of immune response in early infection stages.
CerTest Biotec S.L. · Spain
SARS-CoV-2 self-testing kit for rapid, patient-performed detection of COVID-19 infection. This in vitro diagnostic test enables point-of-care screening with simplified procedures suitable for clinical and home settings.
LumiQuick Diagnostics, Inc. · United States
SARS-CoV-2 rapid immunochromatographic assays for qualitative detection of viral infection. Available in multiple formats including test cards, cups, and dip tests for point-of-care testing in clinical and research settings. Designed for quick, accurate diagnosis to support clinical decision-making.
Monobind Inc. · United States
Point of care diagnostic products designed for rapid testing at the patient location or bedside. These solutions reduce turnaround time and enable immediate clinical decision-making.
Bio-Techne Diagnostics · United States
Diagnostic reagents and controls optimized for point-of-care laboratory applications. Provides rapid results with simplified workflows suitable for decentralized testing.
Shenzhen Dymind Biotechnology Co.,Ltd. · China
Point-of-care testing platform for rapid disease detection and immediate clinical decision-making at bedside or clinic.
Convergent Technologies GmbH & Co. KG · Germany
A fully automated point-of-care RT-PCR system for the qualitative detection of SARS-CoV-2 genetic material in respiratory samples. The system integrates WHO-endorsed RT-PCR methodology with pre-filled, single-use cartridges that perform complete sample processing including RNA extraction, purification, and amplification within 90 minutes. It is designed for use in workplace settings and clinical environments, offering easy operation with minimal hands-on time and reduced exposure to infectious material.
Guangzhou Wondfo Biotech Co., Ltd. · China
Diagnostic testing solution for detection of SARS-CoV-2 virus in patient samples. Supports point-of-care and laboratory-based screening and confirmation of COVID-19 infection.
Shenzhen Dymind Biotechnology Co.,Ltd. · China
Testing platform for rapid detection of SARS-CoV-2. Suitable for screening and confirmation in hospitals, clinics, and point-of-care settings.
Acon Biotech (Hangzhou) Co., Ltd. · China
Rapid diagnostic test for SARS-CoV-2 detection. Provides point-of-care testing capability for COVID-19 screening and confirmation.
Nanjing Liming Bio-products Co., Ltd. · China
Rapid diagnostic test for COVID-19 detection. Designed for quick point-of-care testing in clinical and healthcare settings.
Exactics, Inc. · United States
Point-of-care rapid test for SARS-CoV-2 detection suitable for home-based testing. Delivers results quickly to support early identification and isolation decisions. Reduces need for centralized laboratory processing.
103 more product alternatives available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products